InsiderGauge
Checking updates…
Dashboard

Megna Michael Rinsider trades

In SEC Form 4 filings, Megna Michael R is listed as CHIEF ACCOUNTING OFFICER of Kiniksa Pharmaceuticals International, plc (KNSA). In the last 90 days, Megna Michael R sold $369.4K of Kiniksa Pharmaceuticals International, plc (KNSA) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.

Companies and roles

CompanyRoleTransactionsLast filed
KNSAKiniksa Pharmaceuticals International, plcCHIEF ACCOUNTING OFFICER13Sep 3

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-03

CompanyTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
KNSAKiniksa Pharmaceuticals International, plcSep 3Sep 3S4,600$80.30Sale −$369,38029,062YesForm 4
KNSAKiniksa Pharmaceuticals International, plcSep 1Sep 3M3,932not reportednot reported31,629YesForm 4
KNSAKiniksa Pharmaceuticals International, plcSep 1Sep 3M2,558not reportednot reported34,187YesForm 4
KNSAKiniksa Pharmaceuticals International, plcSep 1Sep 3M2,362not reportednot reported36,549YesForm 4
KNSAKiniksa Pharmaceuticals International, plcSep 1Sep 3M2,644not reportednot reported39,193YesForm 4
KNSAKiniksa Pharmaceuticals International, plcSep 1Sep 3F5,531$79.28$438,49833,662YesForm 4
KNSAKiniksa Pharmaceuticals International, plcSep 1Sep 3A · derivative3,650$0.00$03,650YesForm 4
KNSAKiniksa Pharmaceuticals International, plcSep 1Sep 3A · derivative14,600$79.28$1,157,48814,600YesForm 4
KNSAKiniksa Pharmaceuticals International, plcSep 1Sep 3M · derivative2,644$0.00$07,931YesForm 4
KNSAKiniksa Pharmaceuticals International, plcSep 1Sep 3M · derivative2,362$0.00$04,725YesForm 4
KNSAKiniksa Pharmaceuticals International, plcSep 1Sep 3M · derivative2,558$0.00$02,557YesForm 4
KNSAKiniksa Pharmaceuticals International, plcSep 1Sep 3M · derivative3,932$0.00$0not reportedYesForm 4
KNSAKiniksa Pharmaceuticals International, plcJul 15Sep 3A279$33.50$9,34727,697YesForm 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.